by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen
In five years, Novo Nordisk has created a multiple blockbuster drug in diabetes treatment Ozempic, which has been center stage in transforming the Danish pharmaceutical firm’s sales.
With an approval falling in December 2017, sales of the drug amounted to literally nothing that year. The year after, sales ”barely” reached DKK 1.8bn (USD 273.4m). In 2021, sales were catapulted to nothing less than DKK 33.7bn (USD 5.1bn). With a threshold of USD 1bn, Ozempic is thus a blockbuster five times over.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Ambu board had started headhunting process long before firing of CEO
Thursday’s CEO change had been in the works for a while, says Ambu’s board chair Jørgen Jensen.
Nine new drugs recommended for approval by CHMP at May meeting
During this month’s meeting of the CHMP, the EMA’s expert committee, a total of nine new drugs have been recommended while six drugs have had indication extensions accepted. Two treatments have been rejected.
Britt Meelby Jensen wants to rebuild trust in Ambu
After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.
Outgoing Ambu CEO commends colleagues
”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.
Top news from MedWatch this week
Miss anything?
Biostatistician 
Key Account Manager, Europe and Asia 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Director Global Engineering 
Procurement Process Excellence Specialist 
Senior IT Network Engineer 
Account Manager 
2 Sales Representatives and Product Specialists 
Analytical Coordinator for Analytical Development 
Clinical Trial Manager 
Process Manager 
Client Talent Acquisition Specialist 
Director for innovative pre-clinical testing unit 
CMO Operations Specialist - screening & selection of CMO/CDMO’s